ANDREW WARGO: Open Payments
NPI 1306609458 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,680 in 202 payments from 17 companies in 2025. Trend: 2023 $79 · 2024 $2,608 · 2025 $3,680
Food & beverage: $3,569Education: $111
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 22 | $567 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $408 |
| ABBVIE INC. | 20 | $374 |
| E.R. Squibb & Sons, L.L.C. | 14 | $332 |
| Otsuka America Pharmaceutical, Inc. | 18 | $326 |
| Neurocrine BioSciences, Inc. | 24 | $314 |
| Vanda Pharmaceuticals Inc. | 10 | $245 |
| Corium, LLC | 8 | $218 |
| Teva Pharmaceuticals USA, Inc. | 13 | $168 |
| Collegium Pharmaceutical, Inc. | 12 | $163 |
Products named: CAPLYTA, VRAYLAR, Auvelity, COBENFY, REXULTI, INGREZZA, Azstarys, HETLIOZ.
Industry payments across FL — which companies pay providers there.
